Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Korro Bio, Inc.(KRRO) | 368,085 | 368,085 | 0 | $17.64M | $33.13M | 36.93% | +$15.49M |
| Jasper Therapeutics, Inc.(JSPR) | 0 | 928,964 | +928,964 | $0 | $27.27M | 30.41% | +$27.27M |
| Tourmaline Bio Inc | 641,691 | 741,691 | +100,000 | $16.80M | $16.98M | 18.94% | +$185.3K |
| Hillevax Inc | 558,923 | 558,923 | 0 | $8.97M | $9.29M | 10.36% | +$324.2K |
| Ventyx Biosciences Inc | 686,370 | 412,225 | -274,145 | $1.70M | $2.27M | 2.53% | +$571.9K |
| Kezar Life Sciences Inc | 828,711 | 828,711 | 0 | $785.1K | $747.2K | 0.83% | -$38.0K |
| Elevation Oncology Inc | 2,370,142 | 0 | -2,370,142 | $1.27M | $0 | — | -$1.27M |
| Icosavax Inc | 3,510,228 | 0 | -3,510,228 | $55.32M | $0 | — | -$55.32M |
| Jasper Therapeutics, Inc.(JSPR) | 8,519,648 | 0 | -8,519,648 | $6.72M | $0 | — | -$6.72M |